US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Genprex, Inc.

0.2360

-0.0140-5.60%

Volume:731.53K

Turnover:176.08K

Market Cap:7.82M

PE:-0.09

High:0.2599

Open:0.2549

Low:0.2331

Close:0.2500

Loading ...

Overview Company News Filings

Genprex presents positive preclinical research from studies of GPX-002

Genprex Inc. Announces Promising Preclinical Results for Diabetes Gene Therapy GPX-002 at 2025 ADA Scientific Sessions

Genprex Announces Promising Preclinical Results for Novel Diabetes Gene Therapy Using Non-Viral Lipid Nanoparticle Delivery System at 2025 ADA Conference

Genprex Files for Resale of 15 Million Shares

MT Newswires Live

Genprex files to sell 15M shares of common stock for holders

Genprex Inc. Enters $12.5 Million Share Purchase Agreement with Lincoln Park Capital

Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge

Genprex Inc. Announces Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid Gene Therapy for Small Cell Lung Cancer

Genprex Inc. to Participate in BIO International Convention in Boston

Genprex Inc. Announces Promising Preclinical Results for Novel Diabetes Gene Therapy at ASGCT Annual Meeting

Genprex Q1 EPS $(0.26) Beats $(0.41) Estimate

Genprex Inc expected to post a loss of 41 cents a share - Earnings Preview

BRIEF-Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting

BRIEF-Genprex Signs Agreement With New York University Langone Health

Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma

Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings

Genprex Inc reports results for the quarter ended December 31 - Earnings Summary

Genprex Inc expected to post a loss of 39 cents a share - Earnings Preview

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GNPX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":0.236,"timestamp":1753898519681,"preClose":0.25,"halted":0,"volume":731526,"delay":0,"floatShares":33145048,"shares":33145048,"eps":-2.575835,"marketStatus":"Trading","change":-0.014,"latestTime":"07-30 14:04:06 EDT","open":0.2549,"high":0.2599,"low":0.2331,"amount":176077.97169804,"amplitude":0.1072,"askPrice":0.2367,"askSize":100,"bidPrice":0.235,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":-2.575835,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753905600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":0.25,"preHourTrading":{"tag":"盘前","latestPrice":0.2548,"preClose":0.25,"latestTime":"09:25 EDT","volume":828,"amount":212.0446314,"timestamp":1753881932523},"postHourTrading":{"tag":"盘后","latestPrice":0.2484,"preClose":0.2523,"latestTime":"19:44 EDT","volume":29099,"amount":7286.9727,"timestamp":1753832676719},"volumeRatio":0.873364,"impliedVol":3.1839,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNPX\",,,,,undefined,":{"symbol":"GNPX","floatShares":33145048,"roa":"-128.85%","roe":"-307.08%","lyrEps":-5.339069,"volumeRatio":0.873364,"shares":33145048,"dividePrice":0,"high":0.2599,"amplitude":0.1072,"preClose":0.25,"low":0.2331,"week52Low":0.2023,"pbRate":"2.02","week52High":3.97,"institutionHeld":0,"latestPrice":0.236,"committee":0.99005,"eps":-2.575835,"divideRate":0,"volume":731526,"delay":0,"ttmEps":-2.575835,"open":0.2549,"prevYearClose":0.8516,"prevWeekClose":0.2724,"prevMonthClose":0.2279,"prevQuarterClose":0.2279,"fiveDayClose":0.2568,"twentyDayClose":0.267,"sixtyDayClose":0.29},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNPX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545983238","title":"Genprex presents positive preclinical research from studies of GPX-002","url":"https://stock-news.laohu8.com/highlight/detail?id=2545983238","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545983238?lang=en_us&edition=fundamental","pubTime":"2025-06-24 21:30","pubTimestamp":1750771837,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) announced that its research collaborators presented positive preclinical research from studies of GPX-002, the company’s diabetes ge...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-presents-positive-preclinical-research-from-studies-of-gpx-002-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-presents-positive-preclinical-research-from-studies-of-gpx-002-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPX","BK4139","GNPX"],"gpt_icon":0},{"id":"2545280713","title":"Genprex Inc. Announces Promising Preclinical Results for Diabetes Gene Therapy GPX-002 at 2025 ADA Scientific Sessions","url":"https://stock-news.laohu8.com/highlight/detail?id=2545280713","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545280713?lang=en_us&edition=fundamental","pubTime":"2025-06-24 21:25","pubTimestamp":1750771527,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on June 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDLc3YtwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2545241283","title":"Genprex Announces Promising Preclinical Results for Novel Diabetes Gene Therapy Using Non-Viral Lipid Nanoparticle Delivery System at 2025 ADA Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2545241283","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545241283?lang=en_us&edition=fundamental","pubTime":"2025-06-23 21:01","pubTimestamp":1750683698,"startTime":"0","endTime":"0","summary":"Genprex Announces Promising Preclinical Results for Novel Diabetes Gene Therapy Using Non-Viral Lipid Nanoparticle Delivery System at 2025 ADA Conference. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on June 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL4n8Yn2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2542558309","title":"Genprex Files for Resale of 15 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542558309","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542558309?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:42","pubTimestamp":1749678172,"startTime":"0","endTime":"0","summary":"Genprex (GNPX) filed a registration statement Wednesday for the sale of up to 15 million common shares from time to time on behalf of a selling shareholder, Lincoln Park Capital Fund.The company said it will not receive any of the proceeds from the sale of the shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2542455836","title":"Genprex files to sell 15M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2542455836","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542455836?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:35","pubTimestamp":1749677741,"startTime":"0","endTime":"0","summary":"17:30 EDT Genprex (GNPX) files to sell 15M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genprex-files-to-sell-15m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genprex-files-to-sell-15m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2542653070","title":"Genprex Inc. Enters $12.5 Million Share Purchase Agreement with Lincoln Park Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2542653070","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542653070?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:24","pubTimestamp":1749677091,"startTime":"0","endTime":"0","summary":"On June 11, 2025, Genprex, Inc. entered into a purchase agreement with Lincoln Park Capital Fund, LLC. Under this agreement, Lincoln Park committed to purchase up to $12.5 million in shares of Genprex's common stock. The document does not specify the total number of shares or the price per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL8SxNN7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2542216386","title":"Genprex Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement, Still Faces Minimum Bid Price Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2542216386","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542216386?lang=en_us&edition=fundamental","pubTime":"2025-06-09 19:01","pubTimestamp":1749466873,"startTime":"0","endTime":"0","summary":"Genprex Inc. announced that it has successfully regained compliance with Nasdaq's minimum stockholders' equity requirement, as confirmed in a letter from Nasdaq's Listing Qualifications Department on June 6, 2025. Previously, the company had been notified in November 2024 that it was not meeting the minimum stockholders' equity of $2.5 million. However, based on Genprex's recent quarterly report, Nasdaq has confirmed that the company now meets the necessary requirements, resolving the prior issue. Additionally, Genprex is working to address another compliance matter regarding the minimum bid price of its common stock, which remains below the required $1.00 per share. The company has until August 6, 2025, to rectify this situation and is considering strategies such as a reverse stock split to meet Nasdaq's standards.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL5Yc8PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2540708869","title":"Genprex Inc. Announces Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid Gene Therapy for Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708869","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708869?lang=en_us&edition=fundamental","pubTime":"2025-06-03 22:51","pubTimestamp":1748962304,"startTime":"0","endTime":"0","summary":"Genprex, Inc., based in Austin, TX, has announced the initiation of a Phase 1/2 clinical trial for Quaratusugene Ozeplasmid gene therapy combined with Atezolizumab maintenance therapy in patients with Extensive Stage Small Cell Lung Cancer . This study aims to evaluate the efficacy and safety of the TUSC2 gene encapsulated in lipid-based nanoparticles. The trial will include patients who have shown a complete response, partial response, or stable disease after receiving three to four cycles of standard treatment, which includes atezolizumab, carboplatin, and etoposide. The study's design and methodology include a futility analysis after the 25th patient reaches 18 weeks of follow-up, with patient eligibility criteria focusing on those with an ECOG Performance Status of 0 to 1. Further details are available on Genprex's official website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and tim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDLcDKHj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2540775929","title":"Genprex Inc. to Participate in BIO International Convention in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775929","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775929?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:00","pubTimestamp":1748948437,"startTime":"0","endTime":"0","summary":"Genprex Inc., a clinical-stage gene therapy company, will participate in the BIO 2025 International Convention from June 16-19, 2025, in Boston. The company, which focuses on developing therapies for cancer and diabetes, will have Senior Vice President Thomas Gallagher available for one-on-one meetings to discuss their gene therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire  on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL4lj8Rv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2538642015","title":"Genprex Inc. Announces Promising Preclinical Results for Novel Diabetes Gene Therapy at ASGCT Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2538642015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538642015?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:01","pubTimestamp":1748430061,"startTime":"0","endTime":"0","summary":"Genprex Inc., a clinical-stage gene therapy company, recently announced positive preclinical results for its diabetes gene therapy, GPX-002. Presented at the American Society of Gene and Cell Therapy's 28th Annual Meeting, the study highlights the potential of GPX-002 in treating both Type 1 and Type 2 diabetes. The therapy utilizes intraductal infusion of recombinant adeno-associated virus to deliver Pdx1 and MafA genes, converting alpha cells into insulin-secreting beta-like cells. In mouse models, this approach successfully reversed diabetes without the need for immunosuppression. However, in non-human primate models, an anti-viral immune response was observed, which initially affected glucose tolerance improvements. Researchers found that administering a multi-agent immunosuppression regimen could largely prevent this immune response, sustaining therapeutic effects. Ongoing studies aim to gather further data on the viral efficacy of GPX-002 after six months of immunosuppression in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL2NJCy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2535780754","title":"Genprex Q1 EPS $(0.26) Beats $(0.41) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535780754","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535780754?lang=en_us&edition=fundamental","pubTime":"2025-05-13 05:35","pubTimestamp":1747085744,"startTime":"0","endTime":"0","summary":"Genprex (NASDAQ:GNPX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.41) by 36.59 percent. This is a 92.95 percent increase over losses of $(3.69) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45362999/genprex-q1-eps-0-26-beats-0-41-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2534679234","title":"Genprex Inc  expected to post a loss of 41 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534679234","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534679234?lang=en_us&edition=fundamental","pubTime":"2025-05-10 07:57","pubTimestamp":1746835025,"startTime":"0","endTime":"0","summary":"Genprex Inc  expected to post a loss of41cents a share - Earnings Preview Genprex Inc GNPX.OQ GNPX.O is expected to report results on May 13 (estimated) for the period ending March 31 2025LSEG's mean ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH3W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2531032828","title":"BRIEF-Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531032828","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531032828?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:42","pubTimestamp":1746016927,"startTime":"0","endTime":"0","summary":"BRIEF-Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy April 30 (Reuters) - Genprex Inc GNPX.O:GENPREX COLLABORATORS REPORT POSITIVE PRECLINICAL DATA ON THE US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA24LBHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2531035006","title":"Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035006","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531035006?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"Both REQORSA Alone and in Combination with LUMAKRAS Demonstrated Robust Anti-Tumor Effects in Ras Inhibitor Resistant Non-Small Cell Lung Cancer. In the poster, entitled, \"Overcoming sotorasib acquired resistance in KRASG12C mutant NSCLC by TUSC2 gene therapy,\" researchers demonstrated that TUSC2 gene therapy  effectively overcomes sotorasib  acquired resistance  in KRASG12C mutant NSCLC mouse xenografts. The data indicate that TUSC2 transfection significantly reduced colony formation and markedly increased apoptosis in two AR cell lines. Re-expression of TUSC2 in AR PDXOs significantly decreased the viability of organoids compared with the empty vector. The H23AR tumors exhibited significantly lower sensitivity to sotorasib than their parental counterparts. However, treatment with REQORSA was highly effective in controlling tumor growth compared to treatment with sotorasib alone or the control groups. REQORSA alone also exhibited a strong antitumor effect on TC314AR PDXs. Sotorasib al","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/genprex-collaborators-report-positive-preclinical-113000800.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genprex-collaborators-report-positive-preclinical-113000800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BK4139","AR","GNPX"],"gpt_icon":0},{"id":"2530098034","title":"BRIEF-Genprex Signs Agreement With New York University Langone Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2530098034","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530098034?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:17","pubTimestamp":1745842676,"startTime":"0","endTime":"0","summary":"BRIEF-Genprex Signs Agreement With New York University Langone Health April 28 (Reuters) - Genprex Inc GNPX.O:GENPREX SIGNS EXCLUSIVE TECHNOLOGY LICENSE AGREEMENT WITH NEW YORK UNIVERSITY LANGONE HEAL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUA3VS0P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2530470492","title":"Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530470492","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530470492?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:30","pubTimestamp":1745839800,"startTime":"0","endTime":"0","summary":"Additional Gene Therapy Technology Expands Genprex's Portfolio of Oncology Licenses. \"We are pleased to expand our robust oncology franchise, intellectual property portfolio and research program for REQORSA to continue exploring how it may serve as a therapeutic treatment for some of the most difficult to treat cancers and diseases,\" said Thomas Gallagher, Senior Vice President of Intellectual Property and Licensing. \"We believe REQORSA has the potential to treat mesothelioma, and this license agreement positions Genprex to expand its clinical development pipeline with future clinical studies that are within the scope of the licensed patent.\". Expression of TUSC2 is downregulated in 84% of mesotheliomas. TUSC2 is the tumor suppressor gene used in REQORSA. Research collaborators at NYU presented positive preclinical data from a study of REQORSA for the treatment of mesothelioma at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.According to the Centers for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/genprex-signs-exclusive-technology-license-113000979.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genprex-signs-exclusive-technology-license-113000979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2529730797","title":"Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2529730797","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529730797?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:15","pubTimestamp":1745324100,"startTime":"0","endTime":"0","summary":"Research Journal Features Genprex Collaborators' Abstract Detailing Positive Preclinical Data on the Use ofReqorsa Gene Therapy for the Treatment of Lung Cancer. AUSTIN, Texas, April 22, 2025 /PRNewswire/ -- Genprex, Inc.  , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators' abstract was published in the online Proceedings supplement of Cancer Research, a scientific journal published by the American Association for Cancer Research .Acquired resistance  to Lumakras , the first FDA-approved KRASi, poses a significant challenge in the treatment of KRASG12C mutant NSCLC. Despite initial responses, patients invariably develop resistance, necessitating alternative therapeutic strategies. The mechanisms underlying AR include the emergence of additional mutations in the KRAS gene, reactivation of the KRAS pathway, or activation of alternative signaling pathways. TUSC2, a pot","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/genprex-announces-research-collaborators-abstract-121500003.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genprex-announces-research-collaborators-abstract-121500003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AR","BK4213","GNPX","BK4139"],"gpt_icon":0},{"id":"2524190048","title":"Genprex Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190048","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190048?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:02","pubTimestamp":1743508928,"startTime":"0","endTime":"0","summary":"Genprex Inc reports results for the quarter ended December 31 - Earnings SummaryGenprex Inc GNPX.OQ reported a quarterly adjusted loss of $1.15 per share for the quarter ended December 31, higher than","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL5N3QF0UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2523387056","title":"Genprex Inc  expected to post a loss of 39 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2523387056","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523387056?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:35","pubTimestamp":1743194110,"startTime":"0","endTime":"0","summary":"Genprex Inc  expected to post a loss of39cents a share - Earnings Preview Genprex Inc GNPX.OQ GNPX.O is expected to report results on March 31 (estimated) for the period ending December 31 2024LSEG's ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB1S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2522808897","title":"Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522808897","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522808897?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:15","pubTimestamp":1742991300,"startTime":"0","endTime":"0","summary":"Reqorsa Immunogene Therapy is a Potential Therapy for Ras Inhibitor Resistant Non-Small Cell Lung Cancer. AUSTIN, Texas, March 26, 2025 /PRNewswire/ -- Genprex, Inc.  , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators will present at the upcoming 2025 American Association for Cancer Research  Annual Meeting being held April 25-30, 2025 in Chicago, Illinois. The collaborators will present positive preclinical data from a study of its lead drug candidate, Reqorsa Gene Therapy , for the treatment of KRASG12C mutant non-small cell lung cancer .The data indicate that TUSC2 transfection significantly reduced colony formation in two AR cell lines. Transfection of TUSC2 also markedly increased apoptosis in AR cells. Re-exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/genprex-collaborators-present-positive-preclinical-121500131.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genprex-collaborators-present-positive-preclinical-121500131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","GNPX","AR","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"GNPX","fiscalQuarterEnding":"2025/03","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.26},{"date":"2025-04-01","symbol":"GNPX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743494400000,"name":null,"time":"Pre-Market","dateTimestamp":1743480000000,"actualEps":null},{"market":"US","date":"2024-11-13","symbol":"GNPX","fiscalQuarterEnding":"2024/09","expectedEps":-1.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-1.23},{"market":"US","date":"2024-08-09","symbol":"GNPX","fiscalQuarterEnding":"2024/06","expectedEps":-2.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":3},{"market":"US","date":"2024-05-15","symbol":"GNPX","fiscalQuarterEnding":"2024/03","expectedEps":-2.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-3.69}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNPX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GNPX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GNPX","date":"2025-07-29","current":-0.448682,"percent":0.682708,"low":-21.925059,"twenty":-7.880425,"median":-2.840416,"eighty":-0.284282,"high":-0.045425,"avg":-3.887493,"sd":4.061449,"marketCap":8697260},"quantilePoints":[{"date":"2020-07-31","current":-9.257516,"twenty":-10.153658,"median":-2.821082,"eighty":-1.242849,"marketCap":130180501},{"date":"2020-08-07","current":-9.779453,"twenty":-10.147556,"median":-2.870951,"eighty":-1.242987,"marketCap":137520055},{"date":"2020-08-14","current":-11.312966,"twenty":-10.19761,"median":-2.89384,"eighty":-1.249775,"marketCap":166755320},{"date":"2020-08-21","current":-10.020809,"twenty":-10.406577,"median":-2.926518,"eighty":-1.255733,"marketCap":147708675},{"date":"2020-08-28","current":-10.231773,"twenty":-10.406577,"median":-3.019129,"eighty":-1.256798,"marketCap":150818331},{"date":"2020-09-04","current":-10.09992,"twenty":-10.447432,"median":-3.037652,"eighty":-1.256798,"marketCap":148874796},{"date":"2020-09-11","current":-9.229692,"twenty":-10.412096,"median":-3.057052,"eighty":-1.259201,"marketCap":136047464},{"date":"2020-09-18","current":-10.020809,"twenty":-10.390665,"median":-3.116797,"eighty":-1.261969,"marketCap":147708675},{"date":"2020-09-25","current":-8.886875,"twenty":-10.374174,"median":-3.176468,"eighty":-1.267464,"marketCap":130994272},{"date":"2020-10-02","current":-8.755022,"twenty":-10.347803,"median":-3.250657,"eighty":-1.272846,"marketCap":129050737},{"date":"2020-10-09","current":-9.888956,"twenty":-10.289788,"median":-3.278441,"eighty":-1.277321,"marketCap":145765140},{"date":"2020-10-16","current":-9.862585,"twenty":-10.337255,"median":-3.296963,"eighty":-1.282293,"marketCap":145376432},{"date":"2020-10-23","current":-8.939616,"twenty":-10.289788,"median":-3.371052,"eighty":-1.284365,"marketCap":131771686},{"date":"2020-10-30","current":-8.570429,"twenty":-10.242321,"median":-3.398836,"eighty":-1.28442,"marketCap":126329788},{"date":"2020-11-06","current":-8.280352,"twenty":-10.225919,"median":-3.482186,"eighty":-1.289392,"marketCap":122054010},{"date":"2020-11-13","current":-8.269479,"twenty":-10.212049,"median":-3.732236,"eighty":-1.298407,"marketCap":125195161},{"date":"2020-11-20","current":-8.217141,"twenty":-10.197066,"median":-3.773548,"eighty":-1.309513,"marketCap":124402787},{"date":"2020-11-27","current":-8.086295,"twenty":-10.186518,"median":-3.963765,"eighty":-1.314773,"marketCap":122421850},{"date":"2020-12-04","current":-9.133064,"twenty":-10.162046,"median":-3.982287,"eighty":-1.321372,"marketCap":138269339},{"date":"2020-12-11","current":-8.609679,"twenty":-10.132457,"median":-4.012381,"eighty":-1.330394,"marketCap":130345595},{"date":"2020-12-18","current":-9.316249,"twenty":-10.115743,"median":-4.093421,"eighty":-1.330394,"marketCap":141042650},{"date":"2020-12-24","current":-13.337475,"twenty":-10.189013,"median":-4.16751,"eighty":-1.330508,"marketCap":201921702},{"date":"2020-12-31","current":-11.801817,"twenty":-10.231773,"median":-4.195293,"eighty":-1.330963,"marketCap":178672722},{"date":"2021-01-08","current":-10.721169,"twenty":-10.363626,"median":-4.260121,"eighty":-1.352943,"marketCap":162312328},{"date":"2021-01-15","current":-10.664292,"twenty":-10.415357,"median":-4.322862,"eighty":-1.364217,"marketCap":161451255},{"date":"2021-01-22","current":-11.14774,"twenty":-10.466212,"median":-4.371255,"eighty":-1.368727,"marketCap":168770378},{"date":"2021-01-29","current":-12.711836,"twenty":-10.506027,"median":-4.45103,"eighty":-1.392404,"marketCap":192449895},{"date":"2021-02-05","current":-17.773821,"twenty":-10.66998,"median":-4.49165,"eighty":-1.470198,"marketCap":269085425},{"date":"2021-02-12","current":-20.038417,"twenty":-10.798701,"median":-4.537955,"eighty":-1.518182,"marketCap":303370115},{"date":"2021-02-19","current":-18.06602,"twenty":-10.901429,"median":-4.612044,"eighty":-1.543798,"marketCap":273509148},{"date":"2021-02-26","current":-14.750105,"twenty":-11.016925,"median":-4.704655,"eighty":-1.555884,"marketCap":223308102},{"date":"2021-03-05","current":-14.006882,"twenty":-11.130677,"median":-4.815789,"eighty":-1.555884,"marketCap":212056143},{"date":"2021-03-12","current":-15.09313,"twenty":-11.519089,"median":-4.973229,"eighty":-1.555884,"marketCap":228501313},{"date":"2021-03-19","current":-14.521421,"twenty":-11.767691,"median":-5.112145,"eighty":-1.563616,"marketCap":219845961},{"date":"2021-03-26","current":-10.877819,"twenty":-12.08051,"median":-5.236762,"eighty":-1.574568,"marketCap":195178205},{"date":"2021-04-01","current":-10.178358,"twenty":-11.956128,"median":-5.493575,"eighty":-1.578433,"marketCap":182627944},{"date":"2021-04-09","current":-10.757222,"twenty":-11.802935,"median":-6.19147,"eighty":-1.582943,"marketCap":193014367},{"date":"2021-04-16","current":-9.551256,"twenty":-11.779536,"median":-6.342191,"eighty":-1.589708,"marketCap":171375985},{"date":"2021-04-23","current":-9.358301,"twenty":-11.745645,"median":-6.443704,"eighty":-1.589708,"marketCap":167913844},{"date":"2021-04-30","current":-10.030902,"twenty":-11.728075,"median":-6.506884,"eighty":-1.600096,"marketCap":179982170},{"date":"2021-05-07","current":-9.027812,"twenty":-11.700726,"median":-6.565294,"eighty":-1.61574,"marketCap":161983953},{"date":"2021-05-14","current":-8.763841,"twenty":-11.64428,"median":-6.593258,"eighty":-1.618913,"marketCap":157247580},{"date":"2021-05-21","current":-9.389265,"twenty":-11.534135,"median":-6.635387,"eighty":-1.623652,"marketCap":177140346},{"date":"2021-05-28","current":-9.389265,"twenty":-11.418585,"median":-6.7366,"eighty":-1.628223,"marketCap":177140346},{"date":"2021-06-04","current":-9.21353,"twenty":-11.302943,"median":-6.815539,"eighty":-1.639316,"marketCap":173824885},{"date":"2021-06-11","current":-9.188425,"twenty":-11.23983,"median":-6.84555,"eighty":-1.66412,"marketCap":173351248},{"date":"2021-06-18","current":-8.510591,"twenty":-11.142052,"median":-6.949742,"eighty":-1.691797,"marketCap":160563041},{"date":"2021-06-25","current":-9.01269,"twenty":-11.113614,"median":-6.999729,"eighty":-1.69741,"marketCap":170035787},{"date":"2021-07-02","current":-8.385066,"twenty":-11.079489,"median":-7.065632,"eighty":-1.713098,"marketCap":158194854},{"date":"2021-07-09","current":-7.958281,"twenty":-11.033988,"median":-7.136233,"eighty":-1.725648,"marketCap":150143020},{"date":"2021-07-16","current":-7.280446,"twenty":-11.033988,"median":-7.21558,"eighty":-1.725648,"marketCap":137354814},{"date":"2021-07-23","current":-7.682126,"twenty":-11.00555,"median":-7.278295,"eighty":-1.747551,"marketCap":144933010},{"date":"2021-07-30","current":-7.431076,"twenty":-10.986719,"median":-7.280446,"eighty":-1.781375,"marketCap":140196637},{"date":"2021-08-06","current":-7.355761,"twenty":-10.915877,"median":-7.28958,"eighty":-1.788399,"marketCap":138775725},{"date":"2021-08-13","current":-7.098667,"twenty":-10.915877,"median":-7.28958,"eighty":-1.793889,"marketCap":131176885},{"date":"2021-08-20","current":-6.66143,"twenty":-10.891797,"median":-7.280446,"eighty":-1.802796,"marketCap":123097149},{"date":"2021-08-27","current":-7.844541,"twenty":-10.877819,"median":-7.280446,"eighty":-1.803924,"marketCap":144959963},{"date":"2021-09-03","current":-7.895981,"twenty":-10.864666,"median":-7.298278,"eighty":-1.806855,"marketCap":145910520},{"date":"2021-09-10","current":-7.510184,"twenty":-10.831628,"median":-7.306975,"eighty":-1.822549,"marketCap":138781342},{"date":"2021-09-17","current":-7.330145,"twenty":-10.798701,"median":-7.306975,"eighty":-1.826473,"marketCap":135454392},{"date":"2021-09-24","current":-7.175826,"twenty":-10.767587,"median":-7.298278,"eighty":-1.833664,"marketCap":132602721},{"date":"2021-10-01","current":-6.944348,"twenty":-10.758048,"median":-7.28958,"eighty":-1.835462,"marketCap":128325213},{"date":"2021-10-08","current":-6.352792,"twenty":-10.72838,"median":-7.280446,"eighty":-1.835462,"marketCap":117393806},{"date":"2021-10-15","current":-6.198473,"twenty":-10.698418,"median":-7.255341,"eighty":-1.848012,"marketCap":114542135},{"date":"2021-10-22","current":-5.889836,"twenty":-10.66998,"median":-7.246475,"eighty":-1.885526,"marketCap":108838792},{"date":"2021-10-29","current":-5.992715,"twenty":-10.664292,"median":-7.21558,"eighty":-1.897394,"marketCap":110739906},{"date":"2021-11-05","current":-5.581198,"twenty":-10.571434,"median":-7.175826,"eighty":-1.899493,"marketCap":103135449},{"date":"2021-11-12","current":-5.324,"twenty":-10.54822,"median":-7.149395,"eighty":-1.911083,"marketCap":98382663},{"date":"2021-11-19","current":-4.345777,"twenty":-10.506027,"median":-7.110869,"eighty":-1.9139,"marketCap":83186911},{"date":"2021-11-26","current":-3.946166,"twenty":-10.495479,"median":-7.071943,"eighty":-1.923313,"marketCap":75537540},{"date":"2021-12-03","current":-3.321772,"twenty":-10.494401,"median":-7.032575,"eighty":-1.935366,"marketCap":63585398},{"date":"2021-12-10","current":-3.671432,"twenty":-10.4772,"median":-6.999197,"eighty":-1.959512,"marketCap":70278597},{"date":"2021-12-17","current":-3.446651,"twenty":-10.466212,"median":-6.995787,"eighty":-1.993335,"marketCap":65975826},{"date":"2021-12-23","current":-3.596505,"twenty":-10.456822,"median":-6.982927,"eighty":-2.006865,"marketCap":68844340},{"date":"2021-12-31","current":-3.271821,"twenty":-10.432189,"median":-6.940675,"eighty":-2.007267,"marketCap":62629226},{"date":"2022-01-07","current":-5.544612,"twenty":-10.415963,"median":-6.937002,"eighty":-2.00787,"marketCap":106135025},{"date":"2022-01-14","current":-5.644515,"twenty":-10.412554,"median":-6.869229,"eighty":-2.011978,"marketCap":108047368},{"date":"2022-01-21","current":-4.545583,"twenty":-10.405766,"median":-6.830954,"eighty":-2.019255,"marketCap":87011597},{"date":"2022-01-28","current":-4.570559,"twenty":-10.394679,"median":-6.815749,"eighty":-2.026852,"marketCap":87489683},{"date":"2022-02-04","current":-5.494661,"twenty":-10.391334,"median":-6.786437,"eighty":-2.04254,"marketCap":105178854},{"date":"2022-02-11","current":-5.61954,"twenty":-10.384722,"median":-6.764309,"eighty":-2.057219,"marketCap":107569282},{"date":"2022-02-18","current":-5.519637,"twenty":-10.358352,"median":-6.660476,"eighty":-2.066743,"marketCap":105656939},{"date":"2022-02-25","current":-5.569588,"twenty":-10.337255,"median":-6.635549,"eighty":-2.070777,"marketCap":106613111},{"date":"2022-03-04","current":-5.344806,"twenty":-10.337255,"median":-6.597859,"eighty":-2.076582,"marketCap":102310339},{"date":"2022-03-11","current":-5.269879,"twenty":-10.298955,"median":-6.585551,"eighty":-2.109687,"marketCap":100876082},{"date":"2022-03-18","current":-6.069103,"twenty":-10.258144,"median":-6.558551,"eighty":-2.11784,"marketCap":116174825},{"date":"2022-03-25","current":-5.919248,"twenty":-10.231773,"median":-6.532831,"eighty":-2.134802,"marketCap":113306310},{"date":"2022-04-01","current":-5.448755,"twenty":-10.226597,"median":-6.495202,"eighty":-2.14736,"marketCap":106771748},{"date":"2022-04-08","current":-5.033379,"twenty":-10.222017,"median":-6.428566,"eighty":-2.159223,"marketCap":98632198},{"date":"2022-04-14","current":-4.862342,"twenty":-10.208726,"median":-6.373813,"eighty":-2.163768,"marketCap":95280618},{"date":"2022-04-22","current":-4.275929,"twenty":-10.203063,"median":-6.301353,"eighty":-2.177454,"marketCap":83789489},{"date":"2022-04-29","current":-3.909829,"twenty":-10.193702,"median":-6.197764,"eighty":-2.180591,"marketCap":76615532},{"date":"2022-05-06","current":-3.738774,"twenty":-10.181527,"median":-6.135392,"eighty":-2.190173,"marketCap":73263603},{"date":"2022-05-13","current":-3.866792,"twenty":-10.178493,"median":-6.056629,"eighty":-2.195537,"marketCap":72805493},{"date":"2022-05-20","current":-3.841353,"twenty":-10.144926,"median":-6.018435,"eighty":-2.196279,"marketCap":72326510},{"date":"2022-05-27","current":-3.815913,"twenty":-10.13141,"median":-5.968469,"eighty":-2.196763,"marketCap":71847526},{"date":"2022-06-03","current":-3.790474,"twenty":-10.127823,"median":-5.931736,"eighty":-2.196884,"marketCap":71368542},{"date":"2022-06-10","current":-3.612398,"twenty":-10.114116,"median":-5.915556,"eighty":-2.204416,"marketCap":68015658},{"date":"2022-06-17","current":-3.332564,"twenty":-10.102352,"median":-5.892055,"eighty":-2.209864,"marketCap":62746839},{"date":"2022-06-24","current":-3.561519,"twenty":-10.092603,"median":-5.866707,"eighty":-2.210876,"marketCap":67057691},{"date":"2022-07-01","current":-3.51064,"twenty":-10.078396,"median":-5.844321,"eighty":-2.213751,"marketCap":66099724},{"date":"2022-07-08","current":-3.637837,"twenty":-10.069671,"median":-5.769394,"eighty":-2.218672,"marketCap":68494641},{"date":"2022-07-15","current":-3.663277,"twenty":-10.049506,"median":-5.706955,"eighty":-2.227654,"marketCap":68973625},{"date":"2022-07-22","current":-3.586959,"twenty":-10.029049,"median":-5.694467,"eighty":-2.227654,"marketCap":67536674},{"date":"2022-07-29","current":-3.53608,"twenty":-10.021472,"median":-5.676784,"eighty":-2.227905,"marketCap":66578707},{"date":"2022-08-05","current":-3.637837,"twenty":-10.020809,"median":-5.669491,"eighty":-2.230011,"marketCap":68494641},{"date":"2022-08-12","current":-4.247333,"twenty":-10.017548,"median":-5.651436,"eighty":-2.234588,"marketCap":84995938},{"date":"2022-08-19","current":-4.799246,"twenty":-10.000269,"median":-5.644515,"eighty":-2.235264,"marketCap":96040608},{"date":"2022-08-26","current":-4.487295,"twenty":-9.980272,"median":-5.639221,"eighty":-2.235844,"marketCap":89797968},{"date":"2022-09-02","current":-3.887389,"twenty":-9.968068,"median":-5.61954,"eighty":-2.238194,"marketCap":77792892},{"date":"2022-09-09","current":-4.223337,"twenty":-9.968068,"median":-5.581198,"eighty":-2.23831,"marketCap":84515735},{"date":"2022-09-16","current":-3.767408,"twenty":-9.91647,"median":-5.544612,"eighty":-2.247098,"marketCap":75391877},{"date":"2022-09-23","current":-3.383468,"twenty":-9.888956,"median":-5.522056,"eighty":-2.249454,"marketCap":67708628},{"date":"2022-09-30","current":-3.383468,"twenty":-9.862585,"median":-5.519637,"eighty":-2.25903,"marketCap":67708628},{"date":"2022-10-07","current":-3.287484,"twenty":-9.861864,"median":-5.494661,"eighty":-2.25903,"marketCap":65787816},{"date":"2022-10-14","current":-3.191499,"twenty":-9.836215,"median":-5.47363,"eighty":-2.259652,"marketCap":63867004},{"date":"2022-10-21","current":-3.071518,"twenty":-9.836215,"median":-5.444709,"eighty":-2.260379,"marketCap":61465989},{"date":"2022-10-28","current":-3.383468,"twenty":-9.816568,"median":-5.347983,"eighty":-2.260379,"marketCap":67708628},{"date":"2022-11-04","current":-3.167502,"twenty":-9.816568,"median":-5.344806,"eighty":-2.260379,"marketCap":63386801},{"date":"2022-11-11","current":-3.335476,"twenty":-9.816568,"median":-5.321915,"eighty":-2.260379,"marketCap":66748222},{"date":"2022-11-18","current":-2.713233,"twenty":-9.805788,"median":-5.269879,"eighty":-2.263422,"marketCap":61472414},{"date":"2022-11-25","current":-2.734431,"twenty":-9.793914,"median":-5.195401,"eighty":-2.266011,"marketCap":61952667},{"date":"2022-12-02","current":-2.776825,"twenty":-9.788025,"median":-5.174979,"eighty":-2.271681,"marketCap":62913174},{"date":"2022-12-09","current":-2.681438,"twenty":-9.784238,"median":-5.14919,"eighty":-2.273037,"marketCap":60752034},{"date":"2022-12-16","current":-2.501262,"twenty":-9.783474,"median":-5.120025,"eighty":-2.274386,"marketCap":56669882},{"date":"2022-12-23","current":-2.119714,"twenty":-9.780257,"median":-5.120025,"eighty":-2.266011,"marketCap":48025324},{"date":"2022-12-30","current":-3.073585,"twenty":-9.779453,"median":-5.093623,"eighty":-2.265364,"marketCap":69636719},{"date":"2023-01-06","current":-3.03119,"twenty":-9.770513,"median":-5.045098,"eighty":-2.26917,"marketCap":68676213},{"date":"2023-01-13","current":-3.03119,"twenty":-9.746555,"median":-5.039238,"eighty":-2.272987,"marketCap":68676213},{"date":"2023-01-20","current":-2.771102,"twenty":-9.727712,"median":-5.005179,"eighty":-2.273393,"marketCap":62783506},{"date":"2023-01-27","current":-2.840416,"twenty":-9.715331,"median":-4.970171,"eighty":-2.274717,"marketCap":64353934},{"date":"2023-02-03","current":-3.62471,"twenty":-9.69636,"median":-4.953595,"eighty":-2.274717,"marketCap":82123304},{"date":"2023-02-10","current":-3.264359,"twenty":-9.624923,"median":-4.920219,"eighty":-2.274717,"marketCap":73958998},{"date":"2023-02-17","current":-3.62471,"twenty":-9.618667,"median":-4.866305,"eighty":-2.276872,"marketCap":82123304},{"date":"2023-02-24","current":-2.882811,"twenty":-9.59888,"median":-4.853817,"eighty":-2.285494,"marketCap":65314440},{"date":"2023-03-03","current":-2.615162,"twenty":-9.582151,"median":-4.815789,"eighty":-2.297312,"marketCap":59250448},{"date":"2023-03-10","current":-2.065748,"twenty":-9.55969,"median":-4.781926,"eighty":-2.297312,"marketCap":46802657},{"date":"2023-03-17","current":-1.777392,"twenty":-9.551256,"median":-4.751254,"eighty":-2.274717,"marketCap":40269515},{"date":"2023-03-24","current":-2.064601,"twenty":-9.546139,"median":-4.703273,"eighty":-2.266658,"marketCap":46776670},{"date":"2023-03-31","current":-2.087312,"twenty":-9.544825,"median":-4.625539,"eighty":-2.260379,"marketCap":47291213},{"date":"2023-04-06","current":-1.835201,"twenty":-9.477575,"median":-4.588917,"eighty":-2.257115,"marketCap":41579262},{"date":"2023-04-14","current":-1.854292,"twenty":-9.391461,"median":-4.500911,"eighty":-2.235264,"marketCap":44022044},{"date":"2023-04-21","current":-2.408171,"twenty":-9.372825,"median":-4.45103,"eighty":-2.227654,"marketCap":57171485},{"date":"2023-04-28","current":-1.798466,"twenty":-9.339055,"median":-4.343318,"eighty":-2.213847,"marketCap":42696705},{"date":"2023-05-05","current":-1.72792,"twenty":-9.292981,"median":-4.275929,"eighty":-2.196642,"marketCap":41021888},{"date":"2023-05-12","current":-1.780029,"twenty":-9.240822,"median":-4.204554,"eighty":-2.175296,"marketCap":42258990},{"date":"2023-05-19","current":-1.663988,"twenty":-9.160106,"median":-4.127352,"eighty":-2.151109,"marketCap":39504099},{"date":"2023-05-26","current":-1.59886,"twenty":-9.027812,"median":-4.080458,"eighty":-2.119714,"marketCap":44182216},{"date":"2023-06-02","current":-1.756865,"twenty":-8.976535,"median":-4.071044,"eighty":-2.094469,"marketCap":48548458},{"date":"2023-06-09","current":-1.698553,"twenty":-8.916846,"median":-4.012381,"eighty":-2.071201,"marketCap":46937107},{"date":"2023-06-16","current":-1.599236,"twenty":-8.860505,"median":-3.982287,"eighty":-2.060797,"marketCap":44192612},{"date":"2023-06-23","current":-1.45026,"twenty":-8.813799,"median":-3.963765,"eighty":-2.01972,"marketCap":40075869},{"date":"2023-06-30","current":-1.542429,"twenty":-8.763841,"median":-3.933678,"eighty":-2.00787,"marketCap":42622843},{"date":"2023-07-07","current":-1.604315,"twenty":-8.740526,"median":-3.886391,"eighty":-1.960912,"marketCap":44332955},{"date":"2023-07-14","current":-1.561804,"twenty":-8.639414,"median":-3.843275,"eighty":-1.927191,"marketCap":43158228},{"date":"2023-07-21","current":-1.627075,"twenty":-8.609679,"median":-3.815913,"eighty":-1.899813,"marketCap":44961902},{"date":"2023-07-28","current":-1.512142,"twenty":-8.570756,"median":-3.790474,"eighty":-1.859059,"marketCap":41785898},{"date":"2023-08-04","current":-1.571587,"twenty":-8.520384,"median":-3.771335,"eighty":-1.835462,"marketCap":43428579},{"date":"2023-08-11","current":-1.38046,"twenty":-8.490003,"median":-3.751893,"eighty":-1.822679,"marketCap":38147046},{"date":"2023-08-18","current":-1.177723,"twenty":-8.477195,"median":-3.739595,"eighty":-1.805771,"marketCap":32544700},{"date":"2023-08-25","current":-0.911773,"twenty":-8.477195,"median":-3.714156,"eighty":-1.796113,"marketCap":27215639},{"date":"2023-09-01","current":-1.034378,"twenty":-8.477195,"median":-3.688716,"eighty":-1.788747,"marketCap":30875284},{"date":"2023-09-08","current":-1.00711,"twenty":-8.47978,"median":-3.671432,"eighty":-1.784421,"marketCap":30061369},{"date":"2023-09-15","current":-1.025223,"twenty":-8.482366,"median":-3.663277,"eighty":-1.779269,"marketCap":30601999},{"date":"2023-09-22","current":-0.855447,"twenty":-8.482366,"median":-3.637837,"eighty":-1.759498,"marketCap":25534341},{"date":"2023-09-29","current":-0.756527,"twenty":-8.482366,"median":-3.612398,"eighty":-1.749089,"marketCap":22581673},{"date":"2023-10-06","current":-0.736425,"twenty":-8.482366,"median":-3.599435,"eighty":-1.731376,"marketCap":21981634},{"date":"2023-10-13","current":-0.655816,"twenty":-8.482366,"median":-3.586959,"eighty":-1.702418,"marketCap":19575536},{"date":"2023-10-20","current":-0.615014,"twenty":-8.484951,"median":-3.591732,"eighty":-1.691713,"marketCap":18357634},{"date":"2023-10-27","current":-0.423324,"twenty":-8.49247,"median":-3.599435,"eighty":-1.68314,"marketCap":12635843},{"date":"2023-11-03","current":-0.498988,"twenty":-8.49247,"median":-3.599435,"eighty":-1.649005,"marketCap":14894366},{"date":"2023-11-10","current":-0.44005,"twenty":-8.49247,"median":-3.599435,"eighty":-1.632997,"marketCap":13135095},{"date":"2023-11-17","current":-0.449421,"twenty":-8.49247,"median":-3.599435,"eighty":-1.621882,"marketCap":14163318},{"date":"2023-11-24","current":-0.529069,"twenty":-8.49247,"median":-3.599435,"eighty":-1.614381,"marketCap":16641750},{"date":"2023-12-01","current":-0.457266,"twenty":-8.49247,"median":-3.599435,"eighty":-1.595199,"marketCap":14383226},{"date":"2023-12-08","current":-0.434592,"twenty":-8.490003,"median":-3.59797,"eighty":-1.577064,"marketCap":13670009},{"date":"2023-12-15","current":-0.421365,"twenty":-8.490003,"median":-3.59797,"eighty":-1.555884,"marketCap":13253965},{"date":"2023-12-22","current":-0.394912,"twenty":-8.490003,"median":-3.59797,"eighty":-1.542198,"marketCap":12421877},{"date":"2023-12-29","current":-0.434592,"twenty":-8.49247,"median":-3.599435,"eighty":-1.511616,"marketCap":13670009},{"date":"2024-01-05","current":-0.434592,"twenty":-8.494936,"median":-3.605917,"eighty":-1.486894,"marketCap":13670009},{"date":"2024-01-12","current":-0.409083,"twenty":-8.494936,"median":-3.605917,"eighty":-1.471591,"marketCap":12867638},{"date":"2024-01-19","current":-0.390377,"twenty":-8.497403,"median":-3.612398,"eighty":-1.402651,"marketCap":12279234},{"date":"2024-01-26","current":-0.430435,"twenty":-8.494936,"median":-3.605917,"eighty":-1.372291,"marketCap":13539252},{"date":"2024-02-02","current":-0.346729,"twenty":-8.494936,"median":-3.605917,"eighty":-1.339755,"marketCap":10906285},{"date":"2024-02-09","current":-0.208321,"twenty":-8.494936,"median":-3.605917,"eighty":-1.314773,"marketCap":6552686},{"date":"2024-02-16","current":-0.206904,"twenty":-8.494936,"median":-3.605917,"eighty":-1.284337,"marketCap":6508110},{"date":"2024-02-23","current":-0.207848,"twenty":-8.494936,"median":-3.605917,"eighty":-1.265892,"marketCap":6537828},{"date":"2024-03-01","current":-0.203124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.254668,"marketCap":6389241},{"date":"2024-03-08","current":-0.200763,"twenty":-8.49247,"median":-3.599435,"eighty":-1.240197,"marketCap":6314947},{"date":"2024-03-15","current":-0.196511,"twenty":-8.49247,"median":-3.599435,"eighty":-1.229176,"marketCap":6181219},{"date":"2024-03-22","current":-0.142659,"twenty":-8.49247,"median":-3.599435,"eighty":-1.224346,"marketCap":4487327},{"date":"2024-03-28","current":-0.128016,"twenty":-8.49247,"median":-3.599435,"eighty":-1.215365,"marketCap":4026707},{"date":"2024-04-05","current":-0.185098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.202437,"marketCap":5712218},{"date":"2024-04-12","current":-0.172098,"twenty":-8.494936,"median":-3.605917,"eighty":-1.194249,"marketCap":5311025},{"date":"2024-04-19","current":-0.137394,"twenty":-8.494936,"median":-3.605917,"eighty":-1.157359,"marketCap":4240032},{"date":"2024-04-26","current":-0.13124,"twenty":-8.49247,"median":-3.599435,"eighty":-1.104089,"marketCap":4050134},{"date":"2024-05-03","current":-0.160494,"twenty":-8.49247,"median":-3.599435,"eighty":-1.06657,"marketCap":4952927},{"date":"2024-05-10","current":-0.165255,"twenty":-8.49247,"median":-3.599435,"eighty":-1.034736,"marketCap":5099836},{"date":"2024-05-17","current":-0.183839,"twenty":-8.49247,"median":-3.599435,"eighty":-1.01129,"marketCap":5078849},{"date":"2024-05-24","current":-0.167634,"twenty":-8.49247,"median":-3.599435,"eighty":-0.977772,"marketCap":4631154},{"date":"2024-05-31","current":-0.183563,"twenty":-8.49247,"median":-3.599435,"eighty":-0.959893,"marketCap":5071218},{"date":"2024-06-07","current":-0.207457,"twenty":-8.49247,"median":-3.599435,"eighty":-0.925746,"marketCap":5731315},{"date":"2024-06-14","current":-0.183563,"twenty":-8.494936,"median":-3.605917,"eighty":-0.896806,"marketCap":5071218},{"date":"2024-06-21","current":-0.155498,"twenty":-8.497403,"median":-3.612398,"eighty":-0.856995,"marketCap":4295867},{"date":"2024-06-28","current":-0.14943,"twenty":-8.500834,"median":-3.612398,"eighty":-0.789805,"marketCap":4128223},{"date":"2024-07-05","current":-0.144878,"twenty":-8.500834,"median":-3.612398,"eighty":-0.75175,"marketCap":4002490},{"date":"2024-07-12","current":-0.139569,"twenty":-8.500834,"median":-3.612398,"eighty":-0.725518,"marketCap":3855802},{"date":"2024-07-15","current":-0.145637,"twenty":-8.500834,"median":-3.612398,"eighty":-0.722479,"marketCap":4023446},{"date":"2024-08-02","current":-0.127432,"twenty":-8.515816,"median":-3.637837,"eighty":-0.700599,"marketCap":3520515},{"date":"2024-08-09","current":-0.107711,"twenty":-8.515816,"median":-3.637837,"eighty":-0.696618,"marketCap":2975673},{"date":"2024-08-16","current":-0.06455,"twenty":-8.515816,"median":-3.637837,"eighty":-0.6831,"marketCap":1687473},{"date":"2024-08-23","current":-0.096384,"twenty":-8.515816,"median":-3.637837,"eighty":-0.664031,"marketCap":2519695},{"date":"2024-08-30","current":-0.092434,"twenty":-8.515816,"median":-3.637837,"eighty":-0.649115,"marketCap":2416417},{"date":"2024-09-06","current":-0.068688,"twenty":-8.515816,"median":-3.637837,"eighty":-0.635185,"marketCap":1795669},{"date":"2024-09-13","current":-0.05919,"twenty":-8.515816,"median":-3.637837,"eighty":-0.628095,"marketCap":1547370},{"date":"2024-09-20","current":-0.053684,"twenty":-8.515816,"median":-3.637837,"eighty":-0.596902,"marketCap":1403429},{"date":"2024-09-27","current":-0.048109,"twenty":-8.515816,"median":-3.637837,"eighty":-0.58349,"marketCap":1257688},{"date":"2024-10-04","current":-0.045425,"twenty":-8.515816,"median":-3.637837,"eighty":-0.530036,"marketCap":1187517},{"date":"2024-10-11","current":-0.046774,"twenty":-8.515816,"median":-3.637837,"eighty":-0.525687,"marketCap":1222782},{"date":"2024-10-18","current":-0.046788,"twenty":-8.515816,"median":-3.637837,"eighty":-0.498907,"marketCap":1223142},{"date":"2024-10-25","current":-0.294576,"twenty":-8.515816,"median":-3.637837,"eighty":-0.489223,"marketCap":7700869},{"date":"2024-10-31","current":-0.278058,"twenty":-8.515816,"median":-3.637837,"eighty":-0.475673,"marketCap":7269044},{"date":"2024-11-08","current":-0.232632,"twenty":-8.51619,"median":-3.637837,"eighty":-0.467657,"marketCap":6081527},{"date":"2024-11-15","current":-0.259868,"twenty":-8.51619,"median":-3.637837,"eighty":-0.459349,"marketCap":5901600},{"date":"2024-11-22","current":-0.18064,"twenty":-8.51619,"median":-3.637837,"eighty":-0.455934,"marketCap":4102332},{"date":"2024-11-29","current":-0.408358,"twenty":-8.51619,"median":-3.637837,"eighty":-0.454848,"marketCap":9273794},{"date":"2024-12-06","current":-0.404612,"twenty":-8.51619,"median":-3.637837,"eighty":-0.447819,"marketCap":9188713},{"date":"2024-12-13","current":-0.397119,"twenty":-8.51619,"median":-3.637837,"eighty":-0.445625,"marketCap":9018552},{"date":"2024-12-20","current":-0.337176,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7657261},{"date":"2024-12-27","current":-0.33343,"twenty":-8.51619,"median":-3.637837,"eighty":-0.443656,"marketCap":7572180},{"date":"2025-01-03","current":-0.337514,"twenty":-8.51619,"median":-3.637837,"eighty":-0.44005,"marketCap":7664918},{"date":"2025-01-10","current":-0.288885,"twenty":-8.516564,"median":-3.637837,"eighty":-0.434592,"marketCap":6560571},{"date":"2025-01-17","current":-0.262248,"twenty":-8.516564,"median":-3.637837,"eighty":-0.430359,"marketCap":5955647},{"date":"2025-01-24","current":-0.264122,"twenty":-8.516564,"median":-3.637837,"eighty":-0.419173,"marketCap":5998187},{"date":"2025-01-31","current":-0.228531,"twenty":-8.516564,"median":-3.62471,"eighty":-0.411879,"marketCap":5189921},{"date":"2025-02-07","current":-0.18732,"twenty":-8.516564,"median":-3.621481,"eighty":-0.408358,"marketCap":4254034},{"date":"2025-02-14","current":-0.176456,"twenty":-8.516564,"median":-3.612398,"eighty":-0.404058,"marketCap":4007300},{"date":"2025-02-21","current":-0.14817,"twenty":-8.49247,"median":-3.596505,"eighty":-0.399258,"marketCap":3364940},{"date":"2025-02-28","current":-0.14049,"twenty":-8.420685,"median":-3.561119,"eighty":-0.394912,"marketCap":3190525},{"date":"2025-03-07","current":-0.125505,"twenty":-8.382425,"median":-3.53608,"eighty":-0.389926,"marketCap":2850202},{"date":"2025-03-14","current":-0.134908,"twenty":-8.382425,"median":-3.51064,"eighty":-0.364966,"marketCap":3063755},{"date":"2025-03-21","current":-0.14064,"twenty":-8.370864,"median":-3.479453,"eighty":-0.343245,"marketCap":3193928},{"date":"2025-03-28","current":-0.128127,"twenty":-8.370864,"median":-3.453207,"eighty":-0.330126,"marketCap":2909759},{"date":"2025-04-04","current":-0.171687,"twenty":-8.370864,"median":-3.421602,"eighty":-0.317305,"marketCap":3672082},{"date":"2025-04-11","current":-0.299253,"twenty":-8.367064,"median":-3.383468,"eighty":-0.297933,"marketCap":6400504},{"date":"2025-04-17","current":-0.288525,"twenty":-8.367064,"median":-3.371724,"eighty":-0.294188,"marketCap":6171052},{"date":"2025-04-25","current":-0.300947,"twenty":-8.370864,"median":-3.353576,"eighty":-0.288026,"marketCap":6436733},{"date":"2025-05-02","current":-0.310884,"twenty":-8.370864,"median":-3.332564,"eighty":-0.288026,"marketCap":6649279},{"date":"2025-05-09","current":-0.323984,"twenty":-8.291247,"median":-3.292403,"eighty":-0.288026,"marketCap":6929452},{"date":"2025-05-16","current":-0.295057,"twenty":-8.281861,"median":-3.278689,"eighty":-0.285135,"marketCap":5719394},{"date":"2025-05-23","current":-0.3287,"twenty":-8.281861,"median":-3.263487,"eighty":-0.285135,"marketCap":6371521},{"date":"2025-05-30","current":-0.414924,"twenty":-8.281861,"median":-3.246845,"eighty":-0.285135,"marketCap":8042898},{"date":"2025-06-06","current":-0.339914,"twenty":-8.281861,"median":-3.196134,"eighty":-0.285135,"marketCap":6588896},{"date":"2025-06-13","current":-0.390128,"twenty":-8.281861,"median":-3.167502,"eighty":-0.285135,"marketCap":7562256},{"date":"2025-06-20","current":-0.45194,"twenty":-8.280352,"median":-3.11951,"eighty":-0.284282,"marketCap":8760414},{"date":"2025-06-27","current":-0.350179,"twenty":-8.208524,"median":-3.095514,"eighty":-0.284282,"marketCap":6787870},{"date":"2025-07-03","current":-0.389537,"twenty":-8.161542,"median":-3.071518,"eighty":-0.284282,"marketCap":7550781},{"date":"2025-07-11","current":-0.435329,"twenty":-8.107477,"median":-3.022063,"eighty":-0.284282,"marketCap":8438425},{"date":"2025-07-18","current":-0.424255,"twenty":-8.0232,"median":-2.936322,"eighty":-0.284282,"marketCap":8223766},{"date":"2025-07-25","current":-0.488181,"twenty":-7.893378,"median":-2.861613,"eighty":-0.284282,"marketCap":9462911},{"date":"2025-07-29","current":-0.448682,"twenty":-7.880425,"median":-2.840416,"eighty":-0.284282,"marketCap":8697260}],"updateTime":1753892846312}}}